Company / Current Liabilities per Share
Intellia Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.02
FY2025
5-year range
$1.02 / $1.90
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
#140 of 163
Health Care
What the data says
Intellia Therapeutics, Inc.'s current liabilities per share of $1.02 is lower than 86% of companies in the Health Care sector (FY2025). Current Liabilities per Share has declined for 4 consecutive years, from $1.90 in FY2021 to $1.02 in FY2025.
Based on SEC 10-K filings.
1.02 in FY2025 with a 5-year CAGR of -4.5%.
Improved from $1.32 to $1.02 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -15.7%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
-96.5% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s current liabilities per share has declined for 4 consecutive years.
- In FY2025, current liabilities per share decreased 14.6% year-over-year.
- Ranks #140 out of 163 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.02 | -14.6% |
| FY2024 | $1.19 | -9.9% |
| FY2023 | $1.32 | -22.2% |
| FY2022 | $1.70 | -10.6% |
| FY2021 | $1.90 | +48.4% |
| FY2020 | $1.28 | +62.5% |
| FY2019 | $0.79 | -17.7% |
| FY2018 | $0.96 | +9.9% |
| FY2017 | $0.87 | -37.0% |
| FY2016 | $1.38 | -96.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026